Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Psap
REST API REST API
Mus musculus
Psap is differentially expressed in 275 experiments: 108 organism parts: liver, cerebellum, ... (106 more);, 13 disease states: normal, EL-4 tumor-bearing, ... (11 more);, 71 cell types 20 cell lines 41 compound treatments and 38 other conditions.
Synonyms 'SGP-1'
Orthologs PSAP (Gallus gallus)   Psap (Rattus norvegicus)   ENSCING00000006331 (Ciona intestinalis)   Sap-r (Drosophila melanogaster)   psap (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term extracellular space, developmental growth, lysosome, Golgi apparatus, extracellular region, intracellular membrane-bounded organelle, regulation of MAPKKK cascade, lipid metabolic process, sphingolipid metabolic process, mitochondrion, prostate gland growth, epithelial cell differentiation involved in prostate gland development
InterPro Term SapA, SaposinB, Saposin, SapB_1, SapB_2, Saposin_chordata
Search EB-eye ENSMUSG00000004207
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-3963, E-GEOD-2866, ... (53 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-21515, E-GEOD-19732, E-GEOD-1956, E-MEXP-2554, E-GEOD-18322, ... (7 experiments)

Factor Value U/D Experiments
N1E-115 wild_type
1
E-GEOD-1956
B140P
1
1
E-GEOD-2788
IP14D-101
1
E-GEOD-21515
Swiss19
1
E-GEOD-19732
66cl4
1
E-GEOD-11259
67NR
1
E-GEOD-11259
14 more value(s).


Cell type

studied in E-GEOD-2585, E-GEOD-7069, E-GEOD-7764, E-GEOD-21749, E-GEOD-4142, ... (31 experiments)

Factor Value U/D Experiments
macrophage
2
E-MEXP-1371, E-GEOD-2585
round spermatid
2
E-GEOD-21749, E-GEOD-4193
white preadipocyte
1
E-GEOD-7032
Th2
1
E-TABM-232
cardiac myocyte
1
E-MEXP-1405
GABAergic neuron
1
E-GEOD-2882
65 more value(s).


Disease state

studied in E-GEOD-670, E-MEXP-1296, E-GEOD-21927, E-GEOD-2514, E-GEOD-21543, ... (12 experiments)

Factor Value U/D Experiments
dystrophic
1
1
E-MEXP-1623
bronchoalveolar adenocarcinoma
1
1
E-MEXP-1137
prostate carcinoma
1
E-MEXP-1296
EL-4 tumor-bearing
1
1
E-GEOD-21927
LPS-induced acute lung injury
1
1
E-GEOD-1871
mPIN (mouse prostatic intraepithelial neoplasia)
1
E-GEOD-21543
7 more value(s).


Compound treatment

studied in E-GEOD-6085, E-TABM-903, E-GEOD-1301, E-GEOD-4671, E-TABM-310, ... (31 experiments)

Factor Value U/D Experiments
none
3
9
E-GEOD-5304, E-MEXP-1276, E-GEOD-18649, E-MEXP-1702, E-MEXP-2282, ... (12 experiments)
cardiotoxin
3
E-GEOD-5304, E-MEXP-703, E-GEOD-469
retinoic acid
2
E-TABM-903, E-GEOD-1437
lipopolysaccharide
1
2
E-GEOD-3565, E-GEOD-10246, E-TABM-310
DDA-MPL
1
E-MEXP-1814
interferon-gamma
1
E-GEOD-2973
35 more value(s).


Agent

studied in E-GEOD-26086, E-GEOD-32706

Factor Value U/D Experiments
CD71-24_4h_100nMDex_333uMDMOG
1
1
E-GEOD-26086
fenofibrate
1
E-GEOD-32706
not specified
1
1
E-GEOD-26086
CD71-24_4h_333uMDMOG
1
1
E-GEOD-26086
control
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

Clinical info
studied in E-MEXP-1458

Clinical treatment
studied in E-GEOD-2437

Cohort
studied in E-GEOD-20524, E-GEOD-4356

Developmental stage
studied in E-GEOD-1026, E-GEOD-1479, E-GEOD-8191, E-GEOD-1947, E-MEXP-892, ... (27 experiments)

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Genetic modification
studied in E-GEOD-3172

Genotype
studied in E-GEOD-19684, E-GEOD-7020, E-MEXP-1649, E-MEXP-1587, E-TABM-285, ... (43 experiments)

Growth condition
studied in E-GEOD-1867, E-GEOD-4310, E-GEOD-495, E-GEOD-2253, E-GEOD-2162 ... (5 experiments)

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-MEXP-1717, E-MEXP-1942, E-MEXP-1005

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Irradiate
studied in E-GEOD-4066

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-3594, E-GEOD-5296

Od260
studied in E-GEOD-18858

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-272, E-GEOD-2788, E-GEOD-2640

Protocol type
studied in E-GEOD-12293, E-GEOD-21389, E-GEOD-16192

Replicate
studied in E-GEOD-17112

Rna integrity number
studied in E-GEOD-18858

Route of exposure
studied in E-GEOD-18858

Sampling time point
studied in E-GEOD-4356

Sex
studied in E-GEOD-3463, E-GEOD-75, E-GEOD-97, E-MEXP-1711, E-GEOD-21048 ... (5 experiments)

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902, E-GEOD-15901

Strain or line
studied in E-GEOD-17936, E-TABM-865, E-GEOD-21927, E-TABM-671, E-GEOD-21278, ... (11 experiments)

Treatment
studied in E-MTAB-76, E-GEOD-18344, E-GEOD-21841, E-MEXP-1899, E-MEXP-1375, ... (8 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858, E-GEOD-4356

Units of amount
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.209 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM